Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 February 2025 | Story Lacea Loader
University of the Free State Logo

On 12 February 2025, disruption of academic activities occurred on the Bloemfontein Campus of the University of the Free State (UFS); this followed the disruptions that occurred on 11 February 2025. On the Qwaqwa Campus, attempts to disrupt academic activities also occurred on 12 February 2024.

A memorandum of demands from the Institutional Student Representative Council (ISRC) was handed over to the university management on 11 February 2025, to which management responded; these demands are related to registration and funding. 

Financial concessions have been granted to students on two occasions so far this year to enable them to register. On 10 February 2025, the university granted follow-up concessions.

Furthermore, the institution’s Financial Working Group (FWG) – which includes representatives from the Institutional Student Representative Council (ISRC) – met regularly to determine how it could best assist students to register, taking into consideration the financial constraints of the university.

On the Bloemfontein Campus, 15 students were arrested on 12 February 2025 for transgression of the interdict; internal disciplinary processes are being instituted.

The university’s Protection Services has activated its protest management security escalation plan in accordance with the UFS Protest Management Policy; the situation on the campuses is being closely monitored.

All classes are continuing as normal, and no classes have been suspended. 

It is important to note the NSFAS-related progress made up until now: 

  • NSFAS funding has been confirmed and allocated to 25 551 students.
  • 22 246 of these students have already been successfully registered for the academic year.
  • NSFAS allowances were paid to 14 303 registered students on 3 February 2025.
  • On 17 February 2025, interim allowances will be paid to 7 943 students who were not registered at the time of the first round of payments.
Financial concessions have been granted to students during two occasions so far this year. On 10 February 2025, the university granted the following follow-up concessions: 

1. NSFAS-funded students

Criteria:

  • NSFAS funding for 2025 must be confirmed and reflected on the acknowledgement of debt (AOD) or registration verification document.
  • Historic debt may not exceed R35 000.

Concessions:

  • No payment is required.
  • Students will be eligible for full registration.

Criteria: 

  • NSFAS funding for 2025 must be confirmed and reflected on the acknowledgement of debt (AOD) or registration verification document.
  • Historic debt exceeding R35 000 but not exceeding R50 000.
      Concessions:
  • No payment is required.
  • Students will be eligible for provisional registration. Provisional registration applications must be submitted, and all other terms and conditions will apply.
2. Returning self-paying South African students:

Criteria:
  • Historic debt must not exceed R35 000.
  • Must sign an acknowledgment of debt (AOD).
Concessions:
  • No payment is required.
  • Students will be eligible for provisional registration. Provisional registration applications must be submitted, and all other terms and conditions will apply.
3. Final-year students:
  • Students with an average mark of above 60% were assisted with Monitoring bursaries.
  • 2025 final-year students with an average mark of between 50% and 60% will be assisted with the following concessions.  
Criteria:
  • Final-year students with a pass rate of between 50 and 60% and with outstanding fees up to a maximum of R60 000 to register provisionally.
Concessions:
  • No payment is required.
  • Students must complete a provisional registration application and attach an AOD, covering historic debt plus the first payment required for 2025 registration. 
4. Postgraduate students 
  • The Department of Finance is in contact with the Centre for Postgraduate Support to fast-track funding confirmations.
  • Postgraduate students who have studied at other institutions and wish to register at the UFS must contact Student Finance for possible assistance with registration.

News Archive

Collaboration between UFS and Mayo Clinic to revolutionise cancer treatment
2014-06-27



Attending the lecture were, from the left: Dr Chantel Swart, Prof Lodewyk Kock, Prof Debabrata Mukhopadhyay, Prof James du Preez; back: Prof Pieter van Wyk.
Dr Swart, Profs Kock and Du Preez are from the Department of Microbial, Biochemical and Food Biotechnology. Prof Mukhopadhyay is from the Mayo Clinic (US) and Prof Van Wyk is from the Centre for Microscopy at the UFS.
Photo: Supplied
The UFS made a discovery that may have enormous implications for the treatment of diseases in humans.

Since the discovery, the UFS joined forces with the Mayo Clinic in Rochester, US, in the fight against cancer.

In this collective effort, UFS researchers would be able to assist the Mayo team to:
• see how treatment in cancer patients is progressing,
• target treatments more effectively,
• reduce dosages in order to make treatment gentler on the patient,
• track the effectiveness of the chemotherapy drugs used, and
• gain an accurate view of how the cancer is being eliminated.

Prof Lodewyk Kock, Outstanding Professor at the Department of Microbial, Biochemical and Food Biotechnology, and his team incidentally created a technique to use argon gas particles for the first time on biological material to slice open cells to look inside.

The team that supported Prof Kock includes Dr Chantel Swart, Khumisho Dithebe (PhD student), Prof Hendrik Swart (Department of Physics) and Prof Pieter van Wyk (Centre for Microscopy).

Prof Debabrata Mukhopadhyay from the Mayo Clinic in Rochester, US, got to hear about this breakthrough at the UFS and a collaboration between the two institutions was established.

During a visit to the Bloemfontein Campus, Prof Mukhopadhyay explained novel techniques that make use of gold nanoparticles. These particles attach to chemotherapeutic drugs to selectively target cancer cells – dramatically decreasing the side effects to normal human cells.

For these new drugs (coupled to gold nanoparticles) to be accepted into clinical practice, visual and chemical proof is needed, though. This is where the technique developed by the UFS will play a vital role.

With the technique to look inside cells, the composition, location and metabolism of these drugs can be determined. This will aid in a proof of concept for the application of the nano-drugs. Furthermore, it will enable approval for use of these drugs in clinical trials and eventually could revolutionise cancer treatment as a whole.

For video lectures on the technique used, as well as its findings, follow these links:

1. http://vimeo.com/63643628 (Comic version for school kids)

2. http://vimeo.com/61521401 (Detailed version for fellow scientists)

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept